Ken Herrmann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ken Herrmann

Showing results (121-130 of 721) with videos related to

Pageof 73

Sort By:

Case Reports in Oncology|November 20, 2014

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic CancerVolker Kunzmann, Ken Herrmann, Christina Bluemel, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019

The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerManuel Weber, Ina Binse, James Nagarajah, et al.

European Journal of Nuclear Medicine and Molecular Imaging|April 29, 2015

Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challengesChristina Bluemel, Domenico Rubello, Patrick M Colletti, et al.

Seminars in Nuclear Medicine|December 26, 2025

The value of PSMA PET for risk stratification in prostate cancer: an update and future aspectsCaner Civan, Madeleine J Karpinski, Kambiz Rahbar, et al.

European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2022

Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for traineesRudi Dierckx, Ken Herrmann, Roland Hustinx, et al.

Deutsches Arzteblatt International|June 19, 2025

The Early Detection, Diagnostic Evaluation, and Local Treatment of Prostate Cancer: A Paradigm ShiftPeter Albers, Tobias Franiel, Thomas Kötter, et al.

Seminars in Nuclear Medicine|April 4, 2009

Monitoring response to therapeutic interventions in patients with cancerKen Herrmann, Bernd Joachim Krause, Ralph A Bundschuh, et al.

Endocrine Connections|February 27, 2021